| 216098 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy |
2015-11-04 |
10.1186/2051-1426-3-s2-p34 |
Matsuzaki Junko, Tsuji Takemasa, Luescher Immanuel, Shiku Hiroshi, Mineno Junichi, Okamoto Sachiko, Old Lloyd, Shrikant Protul, Gnjatic Sacha, Odunsi Kunle |
| 216097 |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
Isolation and Culture of Pig Spermatogonial Stem Cells and Their in Vitro Differentiation into Neuron-Like Cells and Adipocytes |
2015-11-04 |
10.3390/ijms161125958 |
Wang Xiaoyan, Chen Tingfeng, Zhang Yani, Li Bichun, Xu Qi, Song Chengyi |
| 216096 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma |
2015-11-04 |
10.1186/2051-1426-3-s2-p125 |
Yaguchi Tomonori, Morii Kenji, Serada Satoshi, Naka Tetsuji, Kawakami Yutaka |
| 216095 |
STEM CELL RESEARCH & THERAPY |
Periostin is critical for improving the therapeutic properties of adipocyte-derived stem cells |
2015-11-04 |
10.1186/s13287-015-0215-x |
Chow Theresa, Rogers Ian M. |
| 216094 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Cryopreserved leukopaks maintain cell viability and functionality: a solution for cell therapy logistics |
2015-11-04 |
10.1186/2051-1426-3-s2-p383 |
Eastwood George, Wang Wenshi, Hexom Tia, Nucho Laura-Marie |
| 216093 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine |
2015-11-04 |
10.1186/2051-1426-3-s2-p427 |
Anastasopoulou Eleftheria A, Tzonis Panagiotis, Fortis Sotirios P, Mahaira Louisa, Vaxevanis Christoforos, Ardavanis Alexandros, Mittendorf Elizabeth A, Peoples George E, Baxevanis Constantin N, Papamichail Michael, Perez Sonia A |
| 216092 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Targeting YAP-dependent MDSC infiltration impairs tumor progression |
2015-11-04 |
10.1186/2051-1426-3-s2-p421 |
Wang Guocan, Lu Xin, Dey Prasenjit, Deng Pingna, Wu Chia Chin, Jiang Shan, Fang Zhuangna, Zhao Kun, Konaparthi Ramakrishna, Hua Sujun, Zhang Jianhua, Li Ning Tapia Elsa M, Kapoor Avnish, Patel Neelay, Guo Zhenglin, Ramamoorthy Vandhana, Tieu Trang, Heffernan Tim, Zhao Di, Shang Xiaoying, Khadka Sunada, Hou Pingping, Hu Baoli, Chang Qing, Troncoso Patricia, Logothetis Christopher, McArthur Mark, Chin Lynda, Wang Y Alan, DePinho Ronald |
| 216091 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune system activation through immunogenic cell death and tumor recruitment of dendritic cells is required for anti-tumor activity of a plant-derived polyphenol rich fraction |
2015-11-04 |
10.1186/2051-1426-3-s2-p301 |
Gomez-Cadena Alejandra, Martinez-Usatorre Amaia, Urueña Claudia, Prieto Karol, Barreto Alfonso, Romero Pedro, Fiorentino Susana |
| 216090 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial |
2015-11-04 |
10.1186/2051-1426-3-s2-p153 |
Haas Naomi B, Stein Mark N, Tutrone Ronald, Perini Rodolfo, Denker Andrew, Mauro David, Fong Lawrence |
| 216089 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Plasma biomarker analysis of ovarian cancer patients undergoing immunotherapy with therapeutic cancer vaccine DPX-Survivac |
2015-11-04 |
10.1186/2051-1426-3-s2-p95 |
Karkada Mohan, Pinto Devanand, Teh Eve, Chisholm Kenneth, Quinton Tara, Berinstein Neil, Mansour Marc |
